Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$3.16 - $7.07 $25,381 - $56,786
-8,032 Reduced 13.04%
53,561 $346,000
Q3 2023

Oct 30, 2023

SELL
$2.24 - $4.61 $27,973 - $57,569
-12,488 Reduced 16.86%
61,593 $244,000
Q2 2023

Aug 03, 2023

BUY
$1.46 - $2.3 $17,520 - $27,599
12,000 Added 19.33%
74,081 $170,000
Q1 2023

Jun 20, 2023

BUY
$1.64 - $2.35 $70,328 - $100,775
42,883 Added 223.37%
62,081 $103,000
Q4 2022

Jan 30, 2023

BUY
$1.73 - $3.77 $5,190 - $11,310
3,000 Added 18.52%
19,198 $47,000
Q3 2022

Nov 14, 2022

BUY
$3.53 - $6.9 $27,879 - $54,496
7,898 Added 95.16%
16,198 $58,000
Q2 2022

Aug 09, 2022

BUY
$4.5 - $8.96 $24,750 - $49,280
5,500 Added 196.43%
8,300 $40,000
Q4 2021

Mar 14, 2022

BUY
$7.09 - $8.7 $14,180 - $17,400
2,000 Added 250.0%
2,800 $2.46 Million
Q3 2021

Mar 07, 2022

BUY
$7.4 - $10.2 $5,920 - $8,159
800 New
800 $6,000

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $153M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Psagot Value Holdings Ltd. Portfolio

Follow Psagot Value Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

News

Stay updated on Psagot Value Holdings Ltd. with notifications on news.